Results

Total Results: 1,426 records

Showing results for "stage".

1221. Disposition of Comments for CER 182 Glasgow Coma Scale (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/field-triage-glascow-disposition-170415.pdf
      January 12, 2017 - Peer Reviewer #1 Introduction appropriately sets the stage for the review Thank you.

1222. Untitled (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/aggression_research-protocol.pdf
      October 05, 2015 - The use of restrictive interventions, such as restraints, at this early stage may only further escalate

1223. Design Specifications for Network Prototype and Cooperative To Conduct Population-Based Studies and Safety Surveillance | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/distributed-network-safety/research
      July 28, 2009 - Design Specifications for Network Prototype and Cooperative To Conduct Population-Based Studies and Safety Surveillance Research Report July 28, 2009 Download Main Document PDF 547.9 KB Author Affiliations Jeffrey Brown, Ph.D. a John Holmes, Ph.D. b Judy Maro, B.A., B.S. c Beth Syat, M.P.H. a Kim…

1224. Systematic Review on Opioid Treatments for Chronic Pain: Surveillance Report 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioids-chronic-pain-surveillance-report-1-final.pdf
      April 01, 2022 - Opioids, and the Mu-opioid Receptor on Progression and Survival in Patients With Newly Diagnosed Stage

1225. Disposition of Comments for Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
      April 25, 2013 - duration, escalation), Hb (baseline, and all recorded values preferably at times specified by protocol), stage … considering the risks-benefits of ESA therapy in the context of a specific patient, with a specific type and stage … Page 100, line 56, 57: inserted text ‘by’ Page 101, line 18: inserted text ‘stage of malignancy, treatment … The BEST study enrolled patients with similar tumor type and stage, but allowed any chemotherapy regimen … Untch et al (n = 729), respectively, both enrolled a patient population with similar tumor type and stage

1226. Colorectal-Cancer-Liver-Metastases-Therapies Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
      December 01, 2012 - Treatment of Colorectal Cancer The diagnosis of CRC requires pathologic review to characterize and stage … I, 64.5 percent for stage IIA, 51.6 percent for stage IIB, 32.3 percent for stage IIC, 74 percent for … IIIA, 45 percent for IIIB, 33.4 percent for IIIC, and 6 percent for stage IV.9 Survival declines … with increasing depth of tumor penetration, increasing tumor stage, and patient age. … Patients with stage III colon cancer who received postsurgical FOLFOX chemotherapy had a 3-year survival

1227. S5 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/s5.pdf
      October 01, 2007 - methods, patient safety, pharmaceuticals, research, statistics (Med Care 2007;45: S5–S8) SETTING THE STAGE

1228. Menopause-Protocol-130612 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
      June 12, 2013 - Source: www.effectivehealthcare.ahrq.gov Published online: June 12, 2013 Evidence-based Practice Center Systematic Review Protocol Project Title: Menopausal Symptoms: Comparative Effectiveness Review of Therapies Original  Date  of  Protocol:  April  3,  2012   Amendment  Date:  June  5, …

1229. Topic Suggestion Description | Effective Health Care Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-women-in-the-postpartum-period-what-is-the-effectiveness-and-safety-of-screening-and-treatment-for-depression-please-use-the-uspstf-framework-which-considers-not-only-screening-but-followup-treatment-and-management-the-tr
      October 01, 2011 - (For example, an ethnic group, stage or severity of a disease.)

1230. Lung Cancer Screening With Low-DoseComputed Tomography (LDCT) (pdf file)
      effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-clin-summary.pdf
      March 01, 2016 - detection and treatment is ideal, only 15 percent of lung cancer cases are diagnosed at an early stage

1231. Topic Suggestion Description | Effective Health Care Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/measurement-and-outcomes-need-consensus-definitions-state-medicaid-programs-need-robust-hedis-and-ncqa-measures-for-all-severe-and-persistent-mental-health-conditions-consensus-definitions-would-help-answer-questions-such-as-
      November 23, 2010 - (For example, an ethnic group, stage or severity of a disease.)

1232. Lung Cancer Screening With Low-DoseComputed Tomography (LDCT) (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/lung-cancer-screening-clin-summary.pdf
      March 01, 2016 - detection and treatment is ideal, only 15 percent of lung cancer cases are diagnosed at an early stage

1233. Topic Suggestion Description | Effective Health Care Program
      effectivehealthcare.ahrq.gov/get-involved/nominated-topics/the-american-college-of-chest-physicians-accp-proposes-to-update-the-following-4-guideline-topics-from-the-2006-publication-on-the-diagnosis-and-management-of-cough-accp-evidence-based-clinical-practice-guidelines1-1-assessin
      January 01, 2006 - (For example, an ethnic group, stage or severity of a disease.)

1234. Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension – An Update of the 2007 Report | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-update/research-protocol
      May 07, 2010 - failure, cerebral vascular disease or events [including stroke], symptomatic coronary artery disease, end-stage … the current search strategy and initial number of abstracts to be included in our abstract screening stage

1235. Disposition of Comments Report for Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-imaging_disposition-comments.pdf
      October 01, 2014 - It is refreshing to see concerns of patient anxiety and quality of life sharing the stage with the … That is, changes in therapeutic management or stage reclassification are appropriate terminal points

1236. Use of Observational Studies in Systematic Reviews of (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
      June 01, 2010 - consultation with clinical experts may also identify important gaps in the RCT evidence at the protocol stage … registry in the United States that enrolls patients who have received ventricular assist devices for end-stage … Well-known or large RCTs should be examined in detail at this stage.

1237. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
      May 01, 2012 - Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and … Hoskin, 201219 -- n = 218 EBRT: n = 108 EBRT + high- dose-rate brachytherapy boost: n = 110 Stage … Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and

1238. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
      May 01, 2012 - Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and … Hoskin, 201219 -- n = 218 EBRT: n = 108 EBRT + high- dose-rate brachytherapy boost: n = 110 Stage … Effectiveness was evident in low-risk disease (PSA <10 ng/ml, stage ²T2a tumors, or Gleason ²6) and

1239. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/cancer-quality-indicator-testing/research
      May 19, 2010 - the cancer registry to identify patients diagnosed in 2006 with one of the following tumor types and stage … At JHH/SKCCC, the cancer registry identified patients with stage IV lung, pancreatic, breast, and colorectal … cancer (and Stage IIIB for lung cancer) disease in 2003-2005 who died 2-15 months after diagnosis.

1240. Gout-managment-protocol-141103 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
      November 03, 2014 - Therefore primary care physicians (PCPs) and emergency physicians are well-positioned to diagnose early-stage … Full-text articles will be dually reviewed; disagreements regarding inclusion at the full-text stage … comorbidities, we will determine whether studies report factors such as sex, duration of the condition, and stage